BioLight Life (Israel) Today
| BOLT Stock | ILS 526.00 90.30 14.65% |
Performance7 of 100
| Odds Of DistressLess than 35
|
BioLight Life is trading at 526.00 as of the 28th of November 2024, a 14.65 percent decrease since the beginning of the trading day. The stock's open price was 616.3. BioLight Life has about a 35 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for BioLight Life Sciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
BioLight Life Sciences Ltd., an ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions comprising glaucoma, dry eye syndrome, and age-related macular degeneration. The company has 4.56 M outstanding shares. More on BioLight Life Sciences
Moving together with BioLight Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
BioLight Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. BioLight Life's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding BioLight Life or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President | Karin Gurevitz |
| Business Concentration | Health Care, Life Sciences Tools & Services, Biotechnology, Healthcare (View all Sectors) |
BioLight Life Sciences (BOLT) is traded on Tel Aviv Stock Exchange in Israel and employs 5 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 31.98 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioLight Life's market, we take the total number of its shares issued and multiply it by BioLight Life's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BioLight Life Sciences operates under Life Sciences Tools & Services sector and is part of Health Care industry. The entity has 4.56 M outstanding shares.
BioLight Life Sciences has accumulated about 39.85 M in cash with (10.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.77.
Check BioLight Life Probability Of Bankruptcy
Ownership AllocationThe market capitalization of BioLight Life Sciences is S31.98 Million. BioLight Life Sciences retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check BioLight Ownership Details
BioLight Life Sciences Risk Profiles
Although BioLight Life's alpha and beta are two of the key measurements used to evaluate BioLight Life's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.47 | |||
| Semi Deviation | 3.84 | |||
| Standard Deviation | 5.89 | |||
| Variance | 34.7 |
BioLight Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in BioLight Life without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
BioLight Life Corporate Management
Elected by the shareholders, the BioLight Life's board of directors comprises two types of representatives: BioLight Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioLight. The board's role is to monitor BioLight Life's management team and ensure that shareholders' interests are well served. BioLight Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioLight Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yifftach CPA | Chief Officer | Profile | |
| Ronit Gross | CoFounder | Profile | |
| Ron MD | Chief Board | Profile | |
| Yaacov Michlin | Chief Officer | Profile |
Other Information on Investing in BioLight Stock
BioLight Life financial ratios help investors to determine whether BioLight Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioLight with respect to the benefits of owning BioLight Life security.